CIHR Late Effects Grant: An Overview

Presentation Description: This session provided an overview of four late effects research studies, funded by CIHR (Canadian Institutes of Health Research):

1) Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors: N-PhenoGENICS
2) Preventing Cardiac Sequelae in Pediatric Cancer Survivors
3) Applying Biomarkers to Long-Term Effects in child and Adolescent Cancer Treatment
4) Early-Detection of Adverse Long-Term Treatment Effects in Childhood Leukemia Survivors


Shinya Ito, MD, FRCPC
Head, Division of Clinical Pharmacology/Toxicology, the Hospital for Sick Children
Professor, University of Toronto

Paul Nathan, MD, MSc, FRCPC
Director, AfterCare Program, The Hospital for Sick Children
Associate Professor, Pediatrics and Health Policy, Management & Evaluation, University of Toronto

Kirk R. Schulz, MD
Director, Childhood Cancer and Blood Research, BC Children’s Hospital and Child and Family Research Insittute, Michael Cuccione Childhood Cancer Research Program
Professor of Pediatrics, University of British Columbia
*NOTE – Kirk Schultz was unable to attend the Symposium. David Malkin (MD, FRCPC) presented his slides.

Daniel Sinnett, PhD
Professor, Department of Pediatrics, Université de Montréal
Research Scientist, Department of Hematology-Oncology, CHU Sainte-Justine Research Center

Comments are closed.